Gelatin Sponge Market - Latest Advancement & Future Trends (2024-2032)

Gelatin Sponge Market Synopsis:

Gelatin Sponge Market Size Was Valued at USD 235.9 Million in 2023, and is Projected to Reach USD 412.28 Million by 2032, Growing at a CAGR of 6.4% From 2024-2032.

The market centered on gelatin sponges is based on the manufacture, marketing, and sale of absorbable gelatin sponge which is utilized in surgical operations for coagulation. These types of sponges are made from purified gelatin and are biodegradable and useful in encouraging clot formation and widely used during surgeries, dentists and in cases related to trauma. With a trend in the advancement of surgery technology to utilize fewer invasions in the body, this market essentially gains greater relevance in the healthcare industries around the world.

The gelatin sponge market has indeed remained stable and has been growing progressively, this is owing to its operational importance in current surgeries. Gelatin sponges are quite popular mainly for their hemostatic action including stemming of flow of blood during surgeries. They come in various types and shapes which make them very useful in many uses because normal sutures may not fit some areas. As information on advanced hemostatic solutions has appeared the constantly growing number of surgeries all around the world, the demand on gelatin sponges has increased tremendously. North America and Europe are the major primary consumers due to expenditure on health care and better and advanced surgeries. But still, the growth rate higher in emerging economy especially in Asia-pacific region due to rising Health care infrastructure and improved access to Surgery.

Additional driving this market is the use of gelatin sponges in outpatient and ambulatory surgical centres. These facilities need products that can effectively manage hemorrhage and with minimal application, the gelatin sponges fill this gap. Since many healthcare organisations focus on the speed of recovery as well as low-price treatments, the use of gelatin sponges gains great importance. This product category is now ubiquitous in a wide range of medical applications, ranging from dental operations to Intensive Care Surgery, further enhancing the market’s resilience, additional to the fundamental demands arising from chronic diseases.

Gelatin Sponge Market Trend Analysis:

Integration of Gelatin Sponges in Minimally Invasive Surgeries

• The changing use of gelatin sponges as a trend in the gelatin sponge market is that gelatin sponges are increasingly being used in MIS. Guided by the tendency toward procedures which help patients spend less time recovering, and allows them to avoid the complications arising after the operation, the need for effective hemostatics, including gelatin sponges, has increased. These sponges rapidly control the bleeding with minimal manipulation, ideal for use in the context of MIS where access to and control of bleeding sites is otherwise difficult. Furthermore, with increased use of biocompatibility and antimicrobial coatings to the gelatin sponges to make them safe for usage, gelatin sponges are being used in the detailed surgery.
• Technologically speaking, MIS appears to be the natural direction to move in and patients are showing a preference for this approach as well. People continue to demand minimal invasive treatment hence health care providers use products that suit the demand. This shows that gelatin sponges have flexibility for different MIS applications and it will keep on driving the growth of the market.

Growth in Developing Regions

• One of the major business opportunities for the market includes emerging nations where the increased usage of gelatin sponges is visible mostly in Asia-Pacific and Latin American countries. People have increased their healthcare usage as governments put their money into healthcare infrastructure, and they are also incrementally subjecting themselves to surgeries best done with efficient hemostatic tools. Increases in healthcare consciousness of advanced surgical methods and the growth of medical tourism occurring in Asian countries like India, Thailand, and Latin American countries such as Brazil are also stimulating demand for gelatin sponges.
• Furthermore, international medical product manufacturers are increasingly focusing on these regions as a growth market either in terms of licensing to local companies and or establishing manufacturing subsidiaries. It not only generates a new form of revenue stream but also gives the access of huge undiscovered market to the industry and therefore makes developing markets as a primary driver of future growth in the gelatin sponge business.

Gelatin Sponge Market Segment Analysis:

Gelatin Sponge Market is Segmented on the basis of type, application, end user, and region

By Type, Porcine segment is expected to dominate the market during the forecast period

• The porcine segment is identified to dominate the gelatin sponge market over the forecast period due to its readily availability and suitable characteristics for use in medical applications. Porcine gelatin sponges which are derived from pig collagen illustrate extremely satisfactory biocompatibility and hemostatic efficacy in surgical operations. The latter source is more efficient with the clotting of blood and the adherence of tissues, especially if it is used during surgery to stop the bleeding. Further, the readily availability and easy affordability of porcine raw materials have made it popular among the health care professions. Growing concerns over effective and cost-effective hemostasis, particularly in the emerging economies with progressive surgical techniques, shall ensure continuity of porcine segment’s control over the blood clotting market.

By Application, Minimally Invasive Surgery segment expected to held the largest share

• The largest segment in the gelatin sponge flow is projected to be MIS many patients prefer surgical methods that have less recovery time and leave a minimum scar on the skin or body in addition to lowering post-operative complications. Gelatin sponges are of great importance in these procedures as they result in good and rapid hemostasis in areas that cannot be easily reached without need for many manipulations, which are otherwise against the principles of MIS. Minimally invasive procedures like LAPAROSCOPY and ENDOSCOPY depend a lot on gelatin sponges for accurate hemostasis making procedures safer and efficient. The increasing amount of MIS procedures across the global market due to technological progress and higher patient demand for minimally invasive treatments further underlines the position of this segment in the gelatin sponge market.

Gelatin Sponge Market Regional Insights:

North America is Expected to Dominate the Market Over the Forecast period

• North American has been the largest market for gelatin sponges in 2023 due to the developed healthcare industry, higher number of surgeries performed, and higher usage of technologies and innovative healthcare products. According to the research, North America occupies one-third to a half of the global market in 2023, the U.S. being the market leader in this region. Another notable factor that confirms the dominance is also important a network of hospitals, outpatient surgery centers and trauma care, which are active in the range of the company and apply hemostatic products. The elaborated high healthcare expenditure and the existence of new technological hemostatic solutions can contribute to the constant consumer demand for gelatin sponges in this region.

Active Key Players in the Gelatin Sponge Market:

• Abbott Laboratories (USA)
• B. Braun Melsungen AG (Germany)
• Baxter International Inc. (USA)
• BD (Becton, Dickinson and Company) (USA)
• Biom'up SA (France)
• CSL Behring LLC (Australia)
• Equimedical (Netherlands)
• Ferrosan Medical Devices A/S (Denmark)
• Gelita Medical (Germany)
• Hemostasis, LLC (USA)
• Integra LifeSciences Holdings Corporation (USA)
• Johnson & Johnson (USA)
• Medtronic plc (Ireland)
• Pfizer Inc. (USA)
• Smith & Nephew plc (UK)
• Other Active Players